Sernova (TSE:SVA) Hits New 12-Month Low – Time to Sell?

Sernova Corp. (TSE:SVA)’s stock price hit a new 52-week low on Wednesday . The company traded as low as C$0.13 and last traded at C$0.13, with a volume of 26804 shares. The stock had previously closed at C$0.14.

Sernova Stock Performance

The stock has a fifty day moving average price of C$0.15 and a 200 day moving average price of C$0.17. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40. The firm has a market cap of C$41.09 million, a price-to-earnings ratio of -2.50 and a beta of 0.73.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.